defining pseudoprogression in lung cancer
Published 7 years ago • 299 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
5:47
defining progression of nsclc on immunotherapy
-
1:00
dr. rizvi on pseudoprogression in lung cancer after immunotherapy
-
7:38
pseudoprogression on immunotherapy in hnscc
-
3:58
time to response to immunotherapy and the concept of pseudoprogression
-
2:01
case study: pseudoprogression in urothelial cancer
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
4:57
pseudoprogression on immunotherapy in squamous nsclc
-
3:05
immunotherapy cancer treatment: what is pseudoprogression?
-
2:41
new targeted and immunotherapy options in lung cancer
-
10:20
imaging 101: immunotherapy criteria
-
8:55
options for mrcc after nivolumab
-
4:29
abscopal effect and pseudoprogression in melanoma
-
5:03
tumour immunology and immunotherapy
-
1:14
dr. kim addresses concerns about hyperprogression in nsclc
-
1:25
dr. paulson discusses acquired resistance to immunotherapy
-
1:30
treatment response assessment in melanoma and the challenge of pseudoprogression with immunotherapy
-
1:11
pd-1 checkpoint inhibition impacts treatment of melanoma and lung cancer
-
1:17:02
resistance to targeted and immunotherapy; what happens next - live recording - september 20, 2022
-
27:43
targeting the immune system with checkpoint inhibitors